Pfizer and BioNTech have asked the FDA to authorize an updated version of their COVID-19 vaccine for this fall — this one designed specifically to target the omicron subvariants that are dominant in the U.S.
The new"bivalent" booster — meaning it's a mix of two versions of the vaccine — will target both the original coronavirus strain and the BA.4 and BA.5 omicron subvariants.
Following the FDA's guidance, the data the drugmakers are submitting represents a departure from what's been used in earlier vaccine authorizations. "We're going to use all of these data that we've learned through not only this vaccine but decades of viral immunology to say: 'The way to be nimble is that we're going to do those animal studies,", an immunobiologist at the University of Arizona College of Medicine in Tucson, told NPR recently."We're really not going out too far on a limb here."
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Myocarditis Risk Higher After COVID-19 Infection than After COVID-19 VaccinationThe risk of myocarditis is substantially higher in the 4 weeks after COVID-19 infection than after a first dose of a COVID-19 vaccine, say researchers of new study. CardioTwitter
Baca lebih lajut »
Pfizer-BioNTech Submits the First Omicron COVID-19 Booster for FDA AuthorizationPfizer-BioNTech Submit the First Omicron COVID-19 Booster for FDA Authorization
Baca lebih lajut »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.
Baca lebih lajut »
Pfizer, BioNTech Seek FDA Authorization for Updated Covid-19 VaccineThe updated shot, which targets the latest Omicron subvariants as well as the original virus, would be used in a fall booster campaign.
Baca lebih lajut »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives
Baca lebih lajut »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.
Baca lebih lajut »